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Abstract
Background: The study of human genetic variation has been advanced by research such as genome-wide association 
studies, which aim to identify variants associated with common, complex diseases and traits. Significant strides have 
already been made in gleaning information on susceptibility, treatment, and prevention of a number of disorders. 
However, as genetic researchers continue to uncover underlying differences between individuals, there is growing 
concern that observed population-level differences will be inappropriately generalized as inherent to particular racial 
or ethnic groups and potentially perpetuate negative stereotypes.
Discussion: We caution that imprecision of language when conveying research conclusions, compounded by the 
potential distortion of findings by the media, can lead to the stigmatization of racial and ethnic groups.
Summary: It is essential that the scientific community and with those reporting and disseminating research findings 
continue to foster a socially responsible dialogue about genetic variation and human difference.
Background
The accomplishments of the Human Genome Project
have ushered in a new genomic era. The mission to deci-
pher our genetic blueprint is being succeeded by a mis-
sion to understand the interplay between genetic factors,
the environment, and human traits in order to promote
health through novel treatments and preventative strate-
gies. Genetic differences that exist between individuals
and groups are a key piece to this complex puzzle.
Referred to as human genetic variation (HGV), these dif-
ferences can be single base changes (single nucleotide
p o l y m o r p h i s m s ,  o r  S N P s )  a s  w e l l  a s  l a r g e  s t r e t c h e s  o f
DNA that are deleted, duplicated, or inverted (i.e., struc-
tural or copy number variations) [1-4]. Knowledge gained
from continued research into HGV holds tremendous
promise for the personalization of medicine by linking
individual genetic information--in addition to non-
genetic risk factors--to disease prevention and drug
response [5]. The expected benefit of individualizing
medical treatments in this way is a more efficient predic-
tion, prevention, diagnosis, and treatment of human dis-
ease.
The recent and rapid technological advances in how we
gather genomic information are driving forces of scien-
tific progress in the genomic era. The development of
"next generation sequencing" techniques, for example,
has caused the price of full genome sequencing to fall
rapidly. The pace at which the field is moving makes pre-
dicting future costs difficult, as estimations are quickly
outdated [6]. For example, the sequencing of Craig Ven-
ter's genome in 2007 [7] and James Watson's genome [8]
in 2008 took approximately two months and cost just
under $1 million dollars; however, Dr. James Lupski of
Baylor College of Medicine recently reported sequencing
his entire genome for $50,000 [9]. This figure will likely
continue to decrease in the near future as indicated by
Complete Genomics' efforts towards a $5000 genome
[10] and the continued interest in personal genomics [11].
Removing cost barriers to obtaining whole-genome data
has dramatically expanded the range of research ques-
tions that geneticists can explore. The increased speed
and accuracy of genetic analysis has made genome-wide
association studies (GWAS)--statistical associations
between known genetic variants and quantitative traits--
a powerful research technique. As a result, the number of
genomic variants associated with diseases and other
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human characteristics has been climbing, with the pace
of discovery quickening dramatically in the past year
[12,13]. As of July 27th 2009, 369 papers describing 1682
SNPs associated with diseases ranging from type I diabe-
tes [14] to narcolepsy [15] and traits such as hip bone size
[16] and height [17] have been published in peer-
reviewed journals http://www.genome.gov/gwastudies.
Most variants identified through GWAS explain only a
small percentage of the associated trait's heritability and
must also be considered within the context of environ-
ment. Translating this type of genetic information into
preventative health and medical interventions, especially
with little existing evidence-based research relevant to
each disease, remains an elusive goal.
Despite uncertainty about the ultimate clinical utility of
many new genetic discoveries, there is no doubt that we
are in an era of large-scale genomic studies which aim to
understand the intricate details of human traits across
different groups and between individuals. Significant
progress has been made in understanding genetic differ-
ences by comparing individuals on the basis of genotype
data rather than social classifications [18]. However,
uncovering these genetic differences has raised important
questions about how to articulate the complex patterns of
human genetic variation that scientists are beginning to
uncover. Allele frequency can be correlated with geo-
graphic ancestry, meaning certain variants may be more
common among individuals whose predecessors lived in
the same area, but translating this type of information
into identifiable groups that are currently meaningful in a
clinical setting has been difficult. Frequently, geneticists
describe "populations" for which their results apply, but
this term can be ambiguous and imprecise and often
refers to current social categories of race and ethnicity,
which are not genetically distinct. Moreover, throughout
history, science has been misused to demonstrate differ-
ences between human groups and rationalize discrimina-
tion. Therefore, it is essential for current and future
research on genetic variation to consider the lessons
learned from past studies of human difference and recog-
nize the current social and political environment in
which results will be contextualized. The caution of accu-
racy and precision in reporting and interpreting genetics
research spans the scientific, media, and public commu-
nities. However, the suggestions laid forth are geared spe-
cifically to genetics and genomics researchers as the study
of human genetic variation continues to advance.
Discussion
Communicating human genetic variation
Two specific examples can help illustrate how research
conceived as scientifically sound and value-independent
can lead to the misrepresentation of the role of genetic
factors in human traits. The first example is a hotly
debated hypothesis that emerged from research on the
role of salt retention in heart disease in African Ameri-
cans beginning in the 1980s. Termed the "Slavery
Hypothesis", the original hypothesis is attributed to Clar-
ence Grim, who published an article titled, Biohistory of
slavery and blood pressure in blacks today. A hypothesis,
with Thomas Wilson in 1991 [19]. The hypothesis asserts
that African Americans--as the descendents of predomi-
nately West Africans who survived the transatlantic slave
trade--possess genetic variants that predispose them to
hypertension and heart disease in the present-day envi-
ronment at a higher rate than the rest of the United States
population. Briefly, the hypothesized mechanism sup-
porting this argument is that the conditions of the middle
passage created a genetic bottleneck, selecting for genes
protective against "...sodium depletion from low sodium
intake or high sodium loss attributable to sweating, diar-
rhea and vomiting, especially when combined with con-
ditions of high environmental temperature and high
physical work demands" [20].
Critics have attacked many aspects of the hypothesis,
specifically its description of the physiology and pathol-
ogy of hypertension to its interpretation of evolutionary
biology theory [21-23]. Despite the questionable scien-
tific and historical support, the Slavery Hypothesis--and
its various reincarnations--are frequently cited in papers
about cardiovascular disease and receive ample positive
attention in the public press. For example, the Slavery
Hypothesis was promoted as scientific fact during an epi-
sode of The Oprah Winfrey Show in May 2007 and by
Harvard economist Roland Fryer during his appearance
on CNN's documentary Black in America in August
2008. In the words of Thomas A. LaVeist, Ph.D., Director
of the Center for Health Disparities at the Bloomberg
School of Public Health at Johns Hopkins University,
"This bogus theory just won't seem to die. Even though
public health researchers have discredited the theory it
continues to be promoted by people who are not knowl-
edgeable about the field" [24].
Research completed on brain size provides a second
illustrative example. In 2005, Bruce Lahn and colleagues
published two papers suggesting that mutations in the
brain developmental genes abnormal spindle-like micro-
cephaly associated (ASPM) and microcephalin, were
under positive selection (i.e., provide an advantage to
individuals who possess them). They reported that such
evidence of selection signaled that the brain is still evolv-
ing and that the two adaptive variants occur at a higher
rate in Eurasian than in African populations [25,26].
Additionally, they speculated that the emergence of these
variants was correlated with the spread of domestication,
the development of cities, and the emergence of written
language [25,26]. The popular press depicted this
research as supporting a link between brain size, intelli-Knerr et al. BMC Medical Genomics 2010, 3:20
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gence, genetics, and race, despite criticism of the study's
findings and their interpretation from other genetic
researchers and follow-up studies with contradictory
results [27,28]. Heated discussion of these studies, their
results, and how they were communicated to and inter-
preted by the public have continued [29] even though
Lahn published subsequent work that concluded early
genetic findings do not support a direct link to cognition
[30].
The previous examples share two common themes.
First, both describe scientists who strongly believed they
were reporting unbiased scientific fact and did not
believe their research was perpetuating racism. Grim and
Robinson stated that they "...do not feel that accusations
of racism belong in a scientific discussion of populations
that differ in physiology or gene frequency" [20]. Lahn
has criticized scientists that, in his view, "start with a
political agenda and fit the evidence to that", going on to
say that any type of bias, "takes credibility from the anti-
racist program I agree with...If someday we discover there
are genetic differences in cognitive abilities, would that
mean that racism is justified?" [31]. The second common
theme from these examples is their ability to lend support
to the ideology that essential, meaningful differences in
fitness and ability exist between human groups. These
cases illustrate how, despite best intentions, studies that
link genetic variation and human difference can lead to
unsubstantiated and often harmful assertions in peer-
reviewed literature and mainstream media.
Scientific efforts to explore differences between groups
can easily become value-laden and misused as "evidence"
to support a certain social perspective. Past and present
stereotypes and existing social structures can both
overtly and unconsciously lead to the portrayal of minor-
ity groups as fundamentally different-- interpreted often
as abnormal, defective, or overly susceptible --when com-
pared to majority groups. In the case of the Slavery
Hypothesis, epidemiologists Jay S. Kaufman and Susan A.
Hall have documented the prevalence of article titles such
as "Hypertension in Blacks. Is it a Different Disease?" and
statements such as,"...hypertension in black subjects is
linked to abnormalities of control of intracellular
sodium," in published articles. Referencing Richard Coo-
per and Charles Rotimi [32], Kaufman and Hall state that
other ethnic groups with hypertension prevalence com-
parable with that of African-Americans, notably the
Finns, are not described as harboring genetic defects or
physiologic abnormalities [33]. Unfortunately, the mis-
representation of scientific findings through misrepre-
sented language persists. In 2008, a study reported that a
variant in the Duffy antigen receptor for chemokines
conferring resistance to malaria was associated with
increased odds of having HIV-1 for the African Ameri-
cans in the study's sample population [34]. Subsequent
press headlines that reported this finding read: "Genetic
Trait Makes Africans Especially Prone to HIV Infection"
[35], "Anti-Malaria Mutation in Blacks Promotes HIV
Infection" [36], and "Anti-malaria gene 'makes Africans
more susceptible to HIV'" [37]. Presenting genetic find-
ings in such a way--with even subtle negative connota-
tions--can have wide-ranging effects. For example, after
Lahn's work on brain size was publicized, National
Review Online columnist John Derbyshire wrote that it
implied, "our cherished national dream of a well-mixed
and harmonious meritocracy...may be unattainable" [38].
Though this statement is an extreme case of research
findings being applied broadly out of context, it illustrates
how discoveries of genetic variation between human
groups can have wide-ranging social implications.
Accurate reporting of research findings
The potential for misinformation about the complex rela-
tionships between genetic factors, environmental factors,
and human phenotypes increases as the number of stud-
ies exploring human genetic variation and complex traits,
such as human behavior, continues to climb. For example,
recent studies have explored genetic variation as it relates
to delinquent peer affiliation in males [39], chaotic family
environments [40], and transsexualism [41]. The conse-
quences of comparing across different groups with
respect to these charged issues are largely unknown, as
most studies have been carried out in a single population.
The general public's lack of understanding about even the
most basic genetics concepts suggest that such studies
have the potential to perpetuate misconceptions about
HGV, likely stigmatizing groups. However, recent calls for
revising the genetics curriculum to focus on complex
traits might help improve public understanding [42].
At the core of many of the controversies outlined above
is the poor representation or misinterpretation of
research outcomes and conclusions. Nuanced statistics,
probabilities, percentages, and the like are quickly boiled
down to a "yes" or "no" when Population A, for example,
is more susceptible to a disease than Population B. The
implications of such simplifications are far greater given
that the subjects associated with these conclusions are
not yeast, or mice, but humans. Concern arises when
Population A no longer reflects a genotype, but a social
grouping, which quickly loses its utility as an accurate
biological indicator. Statements along the lines of "Lati-
nos are more susceptible," or "African Americans are less
susceptible" to disease, drug response, or behavioral traits
do not translate into "all" Latinos or "all" African Ameri-
cans but, rather, a certain fraction of these populations.
We must issue caution to researchers involved in this new
wave of research on HGV that the impact of their find-
ings are not only scientific, but have social, ethical and
clinical implications (e.g., diagnostic implications)Knerr et al. BMC Medical Genomics 2010, 3:20
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[43,44]. When researchers fail to consider or accurately
describe the nuances in associations they observe, they
give the impression that they fail to see, or choose to dis-
miss, the social ramifications of their claims.
Realizing this concern, the issue then becomes what
can the scientific community do to facilitate a responsi-
ble, positive dialogue in the genomic era? A researcher
might begin by considering the basis for examining his or
her particular hypothesis. In exploring a genetic contri-
bution to an apparent health difference, is the milieu
within which this health difference is manifested being
given proper attention? As with any research, confound-
ing factors should be acknowledged and controlled for, if
possible. Considering potential genetic variation in a silo
rather than within the context of environment and other
factors would be an inaccurate reflection of our current
understanding of biological processes. As Yen-Revollo
and colleagues describe with respect to individual drug
response, commonly used racial labels are both insuffi-
cient and inaccurate representations of inferred genetic
clusters in a heterogeneous population [45]. Thus,
researchers should give thought to how the different pop-
ulations in a study have been defined, specifically asking:
have socially determined definitions of race and ethnicity
been used and what are the implications for analyzing
data and reporting results?
These concerns are not meant to halt the progress of
human genetic variation research, but rather meant to
convey a thoughtful "proceed with care" to ensure the
best and most appropriate interpretation and ultimate
utility of results for understanding human difference and
improving human health. To be fair, the burden of
responsibility does not fall squarely on researchers, as
journal editors and the media play an essential role in
how genetic findings are presented. Scientific journals are
the first link in the dissemination of information--selec-
tively culling research findings and presenting them to
the larger scientific community. From scientific journals,
research results then move into the larger public arena
through science and public interest coverage in the main-
stream media. Researchers should give thought to how
the general public and mass media might interpret the
research findings. Thinking through the questions men-
tioned above might preemptively limit the possibility that
results will be misinterpreted or taken out of context.
Writers and researchers should maintain a two-way
dialogue during the process of publishing web and print
articles on genetic findings for the general public--both
are responsible for clarifying misreporting of genetic
findings and presenting corrections in a timely manner.
Individual researchers have the responsibility to contact
reporters who inaccurately present their work and offer
corrections. The internet has a potential for a wider dis-
semination of information than any other current arena
of communication, any stigmas and prejudices that are
provoked by research findings related to human genetic
variation can be perpetuated faster than ever through this
avenue. Critics of science reporting have cited a prolifera-
tion of inaccurate coverage, but studies have shown that
journalists do not necessarily inaccurately report findings
as much as they fail to properly translate the language of
science vocabulary to lay vocabulary [46,47]. The diffi-
culty of translating scientific vocabulary to lay language
and the quest to produce articles that cater to human
interest contributes to the use of sensationalist language
that can overemphasize the significance of genetic find-
ings and increases the perception of unbalanced report-
ing. Scientists should continue to recognize the
importance of accurate reporting so that journalists writ-
ing for the general public avoid inappropriately highlight-
ing the role of genetic factors in differences between
human populations as well as report on the potential lim-
itations and social implications of the research.
Summary
Advancements in genomic research have provided the
scientific community with a deeper appreciation for the
complexity of human genetic variation and its role in
health and disease. The scenarios presented in this paper
describe unintended consequences of attempts to
describe genetic difference (perceived or real) between
groups, which could potentially lead to the creation or
emphasis of disparaging stereotypes and stigmas. How-
ever, identifying a problem often takes much less energy
than implementing a solution. Here we suggest three
ways that human genetic scientists may catalyze a transi-
tion towards increasing social responsibility in the field.
First, researchers should encourage critical reading of
scientific papers and their corresponding media repre-
sentations not only among colleagues, but also among
their families, friends, and peers outside of human genet-
ics. Most importantly, scientists should emphasize special
consideration of how study populations are defined, the
heterogeneity that may exist in these definitions, and the
resulting implications for presentation and application of
results. Encouraging informed and analytical consump-
tion of research findings will facilitate public dialogue
about the relationship between human genetic variation
and social identity. Second, human genetic researchers
must emphasize the responsibility of learning from past
mistakes. This adage is not only applicable to the field
human genetics, but the increasing profile of genetic and
genomics research makes education about past misuses
of genetic information particularly urgent. Finally, the
current vanguard of scientists should commit to cultivat-
ing a generation of human genetic researchers who are
actively engaged in discussions of the social implications
of their work--for whom the responsible design, imple-Knerr et al. BMC Medical Genomics 2010, 3:20
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mentation, and dissemination of their research is a driv-
ing priority. This could be done by actively including
instruction about relevant past misuses of science and
how to prevent them as a part of scientific mentorship.
The genome era has already provided tremendous insight
into the etiology of a number of disorders and created
new and exciting opportunities for researchers to directly
investigate human disease at the population level. By fol-
lowing these and other guidelines [48,49], current and
future scientists can promote a creed of personal respon-
sibility in human genetics research that will allow the
benefits of this era of discovery to be fully realized.
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